Cargando…
A cup of coffee, what else?
INTRODUCTION: Caffeine is the worldwide most frequently consumed psychostimulant. Its availability is nearly unlimited and in Europe it is not subject to state regulation. n the DSM-5 “caffeine use disorder” is categorized as a possible future disorder that currently needs further study. OBJECTIVES:...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528351/ http://dx.doi.org/10.1192/j.eurpsy.2021.629 |
_version_ | 1784801281195376640 |
---|---|
author | Vázquez, P. García Martinez, R. Gomez |
author_facet | Vázquez, P. García Martinez, R. Gomez |
author_sort | Vázquez, P. García |
collection | PubMed |
description | INTRODUCTION: Caffeine is the worldwide most frequently consumed psychostimulant. Its availability is nearly unlimited and in Europe it is not subject to state regulation. n the DSM-5 “caffeine use disorder” is categorized as a possible future disorder that currently needs further study. OBJECTIVES: To describe clinical evaluation, diagnosis, treatment and evolution of a 24 years old female patient. METHODS: A 24-year-old woman admitted to the Dual Pathology Unit with a diagnosis of: unspecified psychotic disorder, mild intellectual disability and borderline disorder. In week 17 of admission, she decided to suspend the medication, with significant improvement. Therapeutic permits increase and Wais-III is repeated, resulting in having a limited intellectual capacity. Two months after being discharged, she was readmitted with manic symptoms. The nursing staff discover that she was drinkiing a large amount of caffeine (up to 4 liters / day). After gradually stopping caffeine intake, she was discharged without psychopharmacological treatment, being able to lead a normalized life, even studying a medium degree. No more incomes were need. RESULTS: Caffeine produces psychomotor-activating, reinforcing, and arousing effects. CONCLUSIONS: The pattern of caffeine use of patients should be considered in the medical practice. The psychostimulant properties of caffeine are reviewed and compared with those of prototypical psychostimulants able to cause substance use disorders. |
format | Online Article Text |
id | pubmed-9528351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95283512022-10-17 A cup of coffee, what else? Vázquez, P. García Martinez, R. Gomez Eur Psychiatry Abstract INTRODUCTION: Caffeine is the worldwide most frequently consumed psychostimulant. Its availability is nearly unlimited and in Europe it is not subject to state regulation. n the DSM-5 “caffeine use disorder” is categorized as a possible future disorder that currently needs further study. OBJECTIVES: To describe clinical evaluation, diagnosis, treatment and evolution of a 24 years old female patient. METHODS: A 24-year-old woman admitted to the Dual Pathology Unit with a diagnosis of: unspecified psychotic disorder, mild intellectual disability and borderline disorder. In week 17 of admission, she decided to suspend the medication, with significant improvement. Therapeutic permits increase and Wais-III is repeated, resulting in having a limited intellectual capacity. Two months after being discharged, she was readmitted with manic symptoms. The nursing staff discover that she was drinkiing a large amount of caffeine (up to 4 liters / day). After gradually stopping caffeine intake, she was discharged without psychopharmacological treatment, being able to lead a normalized life, even studying a medium degree. No more incomes were need. RESULTS: Caffeine produces psychomotor-activating, reinforcing, and arousing effects. CONCLUSIONS: The pattern of caffeine use of patients should be considered in the medical practice. The psychostimulant properties of caffeine are reviewed and compared with those of prototypical psychostimulants able to cause substance use disorders. Cambridge University Press 2021-08-13 /pmc/articles/PMC9528351/ http://dx.doi.org/10.1192/j.eurpsy.2021.629 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Vázquez, P. García Martinez, R. Gomez A cup of coffee, what else? |
title | A cup of coffee, what else? |
title_full | A cup of coffee, what else? |
title_fullStr | A cup of coffee, what else? |
title_full_unstemmed | A cup of coffee, what else? |
title_short | A cup of coffee, what else? |
title_sort | cup of coffee, what else? |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528351/ http://dx.doi.org/10.1192/j.eurpsy.2021.629 |
work_keys_str_mv | AT vazquezpgarcia acupofcoffeewhatelse AT martinezrgomez acupofcoffeewhatelse AT vazquezpgarcia cupofcoffeewhatelse AT martinezrgomez cupofcoffeewhatelse |